Menu Search
Equities

Jacobson Pharma Corporation Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2633:HKG.HZ

Jacobson Pharma Corporation Ltd

Actions
  • Price (HKD)1.27
  • Today's Change0.00 / 0.00%
  • Shares traded180.00k
  • 1 Year change+6.72%
  • Beta0.4037
Data delayed at least 15 minutes, as of Feb 13 2026 07:23 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.

  • Revenue in HKD (TTM)1.53bn
  • Net income in HKD302.58m
  • Incorporated2016
  • Employees1.79k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.